Immedica Pharma AB
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old (NCT05249556) | Immedica Pharma AB | 2027-03-01 |
| Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency (NCT06582524) | Immedica Pharma AB | 2024-08-30 |
| Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia (NCT05299554) | Immedica Pharma AB | 2022-04-01 |
Track Immedica Pharma AB automatically
Every clearance here is in the API, with alerts when new ones post.